Cost-effective Strategies for the Management and Treatment of Urethral Stricture Disease

E Charles Osterberg; Gregory Murphy; Catherine R Harris; Benjamin N Breyer

doi:10.1016/j.ucl.2016.08.002

Cost-effective Strategies for the Management and Treatment of Urethral Stricture Disease

Urol Clin North Am. 2017 Feb;44(1):11-17. doi: 10.1016/j.ucl.2016.08.002.

Authors

E Charles Osterberg¹, Gregory Murphy¹, Catherine R Harris², Benjamin N Breyer³

Affiliations

¹ Department of Urology, University of California, San Francisco, 400 Parnassus Ave, San Francisco, CA 94143, USA.
² Department of Urology, University of California, San Francisco, 400 Parnassus Ave, San Francisco, CA 94143, USA; Department of Urology, Stanford University, 300, Palo Alto, CA 94304, USA.
³ Department of Urology, University of California, San Francisco, 400 Parnassus Ave, San Francisco, CA 94143, USA. Electronic address: Benjamin.breyer@ucsf.edu.

PMID: 27908365
DOI: 10.1016/j.ucl.2016.08.002

Abstract

Following failed endoscopic intervention, the most cost-effective strategy for recurrent urethral stricture disease (USD) is urethroplasty. Inpatient hospital costs associated with urethroplasty are driven by patient comorbidities and postoperative complications. Symptom-based surveillance for USD recurrence will reduce unnecessary diagnostic procedures and cost.

Keywords: Cost-effectiveness; Urethroplasty; Utilization.

Publication types

Review

MeSH terms

Cost of Illness*
Cost-Benefit Analysis
Disease Management*
Guidelines as Topic*
Humans
Male
Urethra / surgery*
Urethral Stricture / economics*
Urethral Stricture / surgery*
Urologic Surgical Procedures, Male / economics*